Dihydergot Yeni Zelanda - İngilizce - Medsafe (Medicines Safety Authority)

dihydergot

novartis new zealand ltd - dihydroergotamine mesilate 1 mg/ml - solution for injection - 1 mg/ml - active: dihydroergotamine mesilate 1 mg/ml

Dihydergot Yeni Zelanda - İngilizce - Medsafe (Medicines Safety Authority)

dihydergot

novartis new zealand ltd - dihydroergotamine mesilate 1mg - tablet - 1 mg - active: dihydroergotamine mesilate 1mg

Dihydergot Yeni Zelanda - İngilizce - Medsafe (Medicines Safety Authority)

dihydergot

novartis new zealand ltd - dihydroergotamine mesilate 2.5mg - tablet - 2.5 mg - active: dihydroergotamine mesilate 2.5mg

Heparin-Dihydergot Yeni Zelanda - İngilizce - Medsafe (Medicines Safety Authority)

heparin-dihydergot

novartis new zealand ltd - dihydroergotamine 0.714 mg/ml; heparin 7142.8 iu/ml; lidocaine 10.66 mg/ml - solution for injection - 0.7 ml - active: dihydroergotamine 0.714 mg/ml heparin 7142.8 iu/ml lidocaine 10.66 mg/ml

Dihydergot 2.5mg Tablets Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

dihydergot 2.5mg tablets

novartis pharmaceuticals australia pty ltd - dihydroergotamine mesylate - tablets - 2.5mg - antimigraine preparations

RULID 150 MG İsrail - İngilizce - Ministry of Health

rulid 150 mg

sanofi - aventis israel ltd - roxithromycin - film coated tablets - roxithromycin 150 mg - roxithromycin - for the treatment of infections caused by microorganisms sensitive to roxithromycin e.g: ent bronchopulmonary, genital and skin manifestations.